Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Mar 23, 2022 1:25pm
134 Views
Post# 34538357

RE:RE:Good Luck ...

RE:RE:Good Luck ...
longrun86 wrote: I bought more shares today.

I don't get caught up too much in the swing in investments but I am very interested in the evolving operations and the ramping up that seems to be going on.

My view is that this isn't firing on all cylinders yet but is certainly stronger than when I bought in.

The market is still asleep to the transition at Knight. It will wake up with a few more good quarters.

LR


Agreed.  This company has a long way to go.

I think we have a lot of internal development to come - strengthening our Mexico position - improving other smaller LATAM positions - and ... bringing on new ROW drugs.  Really, only getting started.

This little cut and paste from GUD's website tells it all ...

Knight is actively looking for potential products and companies that fit within its existing business model, but that are in select areas such as Latin America, Israel, Australia, the Middle-East, Sub-Saharan Africa, and the Caribbean. Knight is interested in acquiring an equity position in companies that are in these high growth countries which are non-core geographies.

It's simply that they won't be forced into a move.  They will do it when they opportunistically find value.  Always ready to talk and always ready to walk away from a deal.  That's just the reality here.

<< Previous
Bullboard Posts
Next >>